MUCOSAL IMMUNE RESPONSE TO GENITAL HSV PRE- AND POST TREATMENT

Medicine & Life Sciences

1. Secretory Leukocyte Peptidase Inhibitor 100%
2. Herpes Genitalis 85%
3. HIV Infections 56%
4. Mucosal Immunity 52%
5. Genitalia 49%
6. Therapeutic Irrigation 48%
7. human neutrophil peptide 4 45%
8. HIV 43%
9. Anti-Infective Agents 43%
10. human neutrophil peptide 1 35%
11. Epithelial Cells 30%
12. Defensins 29%
13. Organized Financing 24%
14. Sexually Transmitted Diseases 20%
15. Infections 20%
16. Innate Immunity 19%
17. Dendritic Cells 18%
18. Macrophages 14%
19. Research Personnel 14%
20. Healthy Volunteers 14%
21. Peptides 13%
22. Cytokines 13%
23. In Vitro Techniques 9%
24. Therapeutics 6%